This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Existing shareholders Atlas Venture and Partners Innovation Fund (PIF), plus new backer The Medicines Co. (TMC), have led an $8mm Series A financing for Annovation Biopharma Inc. (anesthetics and critical care medicines). The round may be expanded to $11mm. Atlas Venture Development Corp. managing director David Grayzel, MD, has joined as executive chairman of the board, and Atlas, PIF, and TMC have contributed board members.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?